Terms & Conditions
1. Introduction and Acceptance of Terms
Welcome to the Mobilab Diagnostic platform operated by Mobilab ("Company", "we", "our" or "us") . This platform comprises an Internet of Things (IoT)-enabled diagnostic device, an Android mobile application used by phlebotomists ("Phlebotomist Application"), and a web-based client dashboard ("Client Dashboard") accessible by business administrators and their authorised personnel ("Dashboard"). These Terms and Conditions of Use (the Terms) constitute a legally binding agreement between you and the Company governing your access to and use of all components of the Platform. By accessing or using any part of the Platform, including logging into the Phlebotomist Application or the Client Dashboard, you acknowledge that you have read, understood, and agree to be bound by these Terms in full. If you are accessing the Platform on behalf of a business entity (Client), you represent and warrant that you have the authority to bind that entity to these Terms. If you do not accept these Terms, you must immediately discontinue use of the Platform.
​
1.1 Role-Based Acknowledgement
​
The Platform serves distinct user roles, each of which is bound by these Terms:
• Phlebotomist: A healthcare professional employed or contracted by a Client who uses the Phlebotomist Application to collect, record, and transmit diagnostic sample data.
• Client Administrator / Business Owner: A registered business entity or its authorised representative who accesses the Client Dashboard to manage clinics, users, bookings, and diagnostic reports.
• Additional Roles: Users created within the Client's portal by the Client Administrator, comprising: Clinic Owner (manages a specific clinic's operations and bookings), Pathologist (reviews and validates diagnostic results from the Mobilab Analyzer), and Reviewer (read-only access to reports and readings for quality or audit purposes). Each user is required to actively accept these Terms (via checkbox or click-through consent) at the point of login. Acceptance is recorded and timestamped by the system for compliance and audit purposes.
2. Definitions
In these Terms, unless context otherwise requires:
​
• Platform — The integrated system comprising the Mobilab Analyzer, Phlebotomist Application, Client Dashboard, and backend server infrastructure.
• Company — Mobilab, a company incorporated under the laws of India, operating from Mobilab, E-12, E Block, Sector 6, Noida, Uttar Pradesh 201301, India.
• Client — A business entity (e.g., a diagnostic laboratory, hospital, or healthcare provider) that has entered into a separate service agreement with the Company and deploys the Platform for its operations.
• Phlebotomist — A licensed healthcare professional authorised by a Client to use the Phlebotomist Application for sample data collection and transmission.
• Mobilab Analyzer — The Company-manufactured diagnostic hardware device that interfaces with biological samples (blood, serum, plasma) and transmits readings to the backend server via the Phlebotomist Application.
• Reagents — Proprietary chemical reagents supplied by Mobilab for use exclusively with the Mobilab Analyzer. Each diagnostic test (e.g., Albumin, Bilirubin, Glucose, Creatinine, and other biochemical parameters) requires a specific Reagent cartridge/vial as specified in the product documentation supplied with the order.
• Patient Data — All data, measurements, and readings derived from patient samples processed through the Mobilab Analyzer.
• User Account — The unique credentials assigned to an individual user to access the Platform.
• Backend Server — The Django-based server infrastructure maintained by the Company that receives, processes, stores, and makes accessible all device and application data.
• Clinic — A sub-unit created within the Client Dashboard by the Client Administrator to organise bookings and phlebotomist assignments.
• Booking — A scheduled or completed patient sample collection event recorded within the Platform.
• ISO 13485 — International standard specifying requirements for a quality management system applicable to medical device organisations.
• ISO 27001 — International standard for information security management systems.
• IEC 62443 — International standard for cybersecurity of industrial automation and control systems, applied here to Mobilab Analyzer infrastructure.
• DPDP Act — Digital Personal Data Protection Act, 2023 of India.
• IT Act — Information Technology Act, 2000 of India.
3. Eligibility and User Registration
3.1 General Eligibility
​
To use the Platform, you must:
• Be at least 18 years of age;
• Be a registered professional (Phlebotomist) or an authorised business representative (Client);
• Have been granted access credentials by the Company or by an authorised Client Administrator;
• Comply with all applicable laws and professional licensing requirements in your jurisdiction.
​
3.2 Account Registration and Credentials
​
Access credentials for the Platform are issued and managed as follows:
• Phlebotomist Accounts: Created, managed, and deactivated by the Client Administrator within the Client Dashboard. The Client Administrator has full authority to create, modify, suspend, or permanently revoke a phlebotomis's access at any time without requiring approval from Mobilab.
• Client Administrator Accounts: Provisioned directly by Mobilab's Operations Team. Only Mobilab Operations may create, modify, suspend, or revoke Client Administrator credentials.
• Additional Roles (Clinic Owner, Pathologist, Reviewer): Created and managed by the Client Administrator within their portal scope.
​​​
Mobilab's Operations Team additionally reserves the right to suspend or revoke any user's access credentials across all roles — at any time, without prior notice, where this is necessary for security, compliance, investigation of a breach, or protection of patient data integrity. Such action may be taken independently of, or in coordination with, the relevant Client Administrator.
You are solely responsible for maintaining the confidentiality of your login credentials. You agree to:
• Notify Mobilab Operations (via legal@mobilab.in) or your Client Administrator immediately upon any suspected unauthorised access to your account;
• Not share your credentials with any third party under any circumstances;
• Log out after each session on shared or public devices;
• Accept full responsibility for all activities conducted under your account credentials until access is formally revoked.
​
3.3 Access Revocation and Account Termination
​
Access to the Platform may be revoked or an account terminated under the following circumstances:
​
• By the Client Administrator: The Client Administrator may immediately revoke or suspend access for any phlebotomist or other user within their organisation. This may be done at any time through the Client Dashboard without requiring Mobilab's involvement.
• By Mobilab's Operations Team: Mobilab reserves the right to suspend, restrict, or permanently terminate access for any user or Client account — including Client Administrator accounts — where there is: a. a breach or suspected breach of these Terms; b. a security incident or threat; c. misuse of the Mobilab Analyzer or Platform; d. a violation of applicable law; e. non-payment or expiry of the Client's service agreement; or (f) any other operational or compliance reason at Mobilab' s reasonable discretion. Mobilab Operations may act with or without prior notice depending on the severity of the situation.
• By the User: Users may request deactivation of their own account by contacting their Client Administrator or Mobilab at legal@mobilab.in.
​
​Upon revocation or termination, all access to the Platform shall cease immediately. Data associated with the account will be retained in accordance with the data retention schedule set out in the Privacy Policy. Revocation of a user's account does not affect the validity or enforceability of any obligation that arose prior to termination.
4. Permitted and Prohibited Use of the Platform
4.1 Permitted Use
​
You are authorised to use the Platform solely for the following purposes:
• Phlebotomists: Collection of patient samples in a professional clinical context; transmission of device readings to the backend server via the Phlebotomist Application; viewing of assigned bookings and patient records relevant to their role.
• Client Administrators: Management of Clinics, Users, and Bookings within their authorised portal; access to diagnostic reports and data generated by their own phlebotomists; configuration of role-based access for their staff.
• All Users: Viewing of own profile and role-specific data; accepting platform updates and policy changes.
​
4.2 Prohibited Conduct
​
You expressly agree NOT to:
​
• Access, tamper with, or use the data, accounts, or records of another Client or any individual not under your authorized scope;
• Attempt to reverse-engineer, decompile, disassemble, or otherwise derive the source code of the Phlebotomist Application, the Client Dashboard, or the firmware of the Mobilab Analyzer;
• Introduce viruses, malicious code, or any software designed to disrupt, damage, or gain unauthorized access to the Platform or backend infrastructure;
• Use the Platform for any purpose that is fraudulent, deceptive, or otherwise violates applicable law;
• Scrape, mine, or harvest data from the Platform without explicit written authorisation from the Company;
• Attempt to circumvent authentication or security mechanisms;
• Use the Platform to process data for any purpose other than that authorised by the relevant Client's service agreement;
• Share, sell, license, or otherwise transfer your account or Platform access to any third party;
• Misuse the Mobilab Analyzer in a manner inconsistent with its intended clinical purpose or the manufacturer's specifications.
5. Mobilab Analyzer — Use, Responsibility, and Disclaimers
5.1 Device Authorisation
​
The Mobilab Analyzer is a proprietary diagnostic instrument developed and distributed by Mobilab. It is designed exclusively for use in a professional healthcare context by trained and licensed phlebotomists. The Device is provided under a separate commercial agreement between the Company and the Client.
5.2 Clinical Use and Reagents
The Mobilab Analyzer is intended solely for in-vitro diagnostic testing of blood, serum, and plasma samples in a professional setting. It must not be used:
• For self-testing or home use by patients;
• For diagnostic conclusions outside the scope of validated test parameters;
• Without appropriate clinical oversight. The Mobilab Analyzer operates in conjunction with Mobilab-supplied Reagents. Users must:
• Use only Reagents supplied or approved by Mobilab for use with the Analyzer;
• Handle, store, and dispose of Reagents in accordance with the product insert and applicable bio-safety and chemical handling regulations;
• Not use expired, damaged, or third-party reagents, as these may produce inaccurate
results and void any quality warranty on test outcomes;
• Ensure each test type (e.g., Albumin, Bilirubin, Glucose, Creatinine) uses the
corresponding Reagent specified in the Mobilab product documentation.
​
5.3 Device and Reagent Integrity
​
You must not physically tamper with, modify, or alter the Mobilab Analyzer or its firmware. Similarly, Reagents must not be diluted, mixed with non-approved substances, or used outside their specified storage and temperature conditions. Any such interference voids the product warranty, may render results clinically unreliable, and may constitute a violation of applicable medical device regulations under the Medical Devices Rules, 2017 (India).
​
5.4 Data Accuracy
​
The Company makes reasonable efforts to ensure the accuracy and reliability of device readings. However, diagnostic results transmitted through the Platform should be interpreted by qualified healthcare professionals and should not be used as the sole basis for clinical decision- making without appropriate validation.
​
5.5 Connectivity and Data Transmission
The Device transmits data through the Phlebotomist Application over a network connection. The Company is not liable for data loss, transmission errors, or delays caused by network failures, device malfunction outside normal operating parameters, or improper use of the Device.
6. Data Ownership and Intellectual Property
6.1 Company Intellectual Property
All software, firmware, algorithms, source code, documentation, trademarks, trade names, logos, and other intellectual property associated with the Platform (including the Phlebotomist Application, Client Dashboard, Mobilab Analyzer firmware, and backend infrastructure) are theexclusive property of Mobilab or its licensors. Nothing in these Terms grants you any ownership right or interest in such intellectual property.
6.2 Client and Patient Data
All diagnostic data, patient records, booking information, and readings generated through Client operations on the Platform remain the property of the respective Client, subject to the Company's right to process such data for the purpose of service delivery. The Company is a data processor acting on behalf of Clients as data controllers (or co-controllers, as applicable) under the DPDP Act, 2023. Patient data is processed only to the extent necessary to fulfil the diagnostic service. The Company does not claim ownership of patient data and will not use it for any commercial purpose.
6.3 Feedback and Suggestions
If you provide the Company with feedback, suggestions, or ideas regarding the Platform, you grant the Company a non-exclusive, worldwide, royalty-free, irrevocable licence to use such feedback for any purpose without obligation of compensation or attribution.
7. Security, Compliance, and Quality Standards
7.1 Information Security (ISO 27001)
​
The Company maintains an Information Security Management System (ISMS) aligned with ISO/IEC 27001. This includes controls for access management, data encryption in transit and at rest, vulnerability management, incident response, and audit logging. Security is reviewed periodically through internal and external audits.
7.2 Medical Device Quality (ISO 13485)
The Company's quality management system for medical devices is developed in accordance with ISO 13485. This standard governs the design, development, and post-market surveillance of the Mobilab Analyzer and associated software. All device data pathways have been validated as part of the Company's quality assurance programme.
7.3 IoT Cybersecurity (IEC 62443)
The Company applies cybersecurity principles based on IEC 62443 to its Mobilab Analyzer infrastructure. This includes device authentication, secure firmware update mechanisms, network segmentation, and monitoring for anomalous device behaviour.
​
7.4 User Obligations for Security
​
You are responsible for maintaining the security of your access credentials and device. You must:
• Use strong, unique passwords for your account;
• Ensure that devices used to access the Platform are protected by appropriate security controls (PIN, biometric lock, etc.);
• Report any suspected security breach, data exposure, or unauthorised access immediately to the Company at legal@mobilab.in;
• Comply with any additional security requirements communicated by the Company or your Client Administrator.
​
Mobilab Operations Team — Security Oversight
Mobilab's internal Operations Team is responsible for monitoring Platform access, managing server-side credentials, responding to security alerts, and executing access revocations where required. The Operations Team may contact a Client Administrator or directly intervene in an account where a security risk is identified. All such actions are logged and subject to Mobilab's internal security governance procedures under its ISO 27001 ISMS.
8. Service Availability and Maintenance
The Company endeavours to maintain high availability of the Platform. However, you
acknowledge that:
• The Platform may experience scheduled downtime for maintenance, updates, and upgrades. The Company will endeavour to provide advance notice of planned maintenance where practicable.
• Unscheduled outages may occur due to factors outside the Company's control, including third-party infrastructure failures, network disruptions, or force majeure events.
• The Company does not guarantee uninterrupted, error-free, or real-time access to the Platform.
• Critical diagnostic decisions should not be made solely during periods of known system instability.​
9. Disclaimers and Limitation of Liability
9.1 Medical Disclaimer
THE PLATFORM, INCLUDING THE IOT DEVICE AND ALL ASSOCIATED SOFTWARE, IS PROVIDED AS A DIAGNOSTIC TOOL FOR USE BY TRAINED HEALTHCARE PROFESSIONALS. IT DOES NOT CONSTITUTE MEDICAL ADVICE AND MUST NOT REPLACE THE INDEPENDENT CLINICAL JUDGMENT OF A QUALIFIED PHYSICIAN OR HEALTHCARE PROVIDER. THE COMPANY IS NOT RESPONSIBLE FOR CLINICAL OUTCOMES ARISING FROM THE USE OR MISUSE OF DIAGNOSTIC RESULTS.
9.2 Warranty Disclaimer
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, THE PLATFORM IS PROVIDED "AS IS" AND "AS AVAILABLE" WITHOUT WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, OR ACCURACY OF RESULTS.
​
9.3 Limitation of Liability
IN NO EVENT SHALL THE COMPANY, ITS DIRECTORS, OFFICERS, EMPLOYEES, AGENTS, OR AFFILIATES BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION LOSS OF PROFITS, DATA, REVENUE, OR BUSINESS OPPORTUNITY, ARISING OUT OF OR IN CONNECTION WITH YOUR USE OF THE PLATFORM, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
THE COMPANY'S TOTAL LIABILITY TO ANY USER OR CLIENT FOR DIRECT DAMAGES ARISING FROM USE OF THE PLATFORM SHALL NOT EXCEED THE TOTAL FEES PAID BY THE CLIENT TO THE COMPANY IN THE TWELVE (12) MONTHS PRECEDING THE DATE OF THE CLAIM.
9.4 Force Majeure
Mobilab shall not be liable for any failure or delay arising from causes beyond its reasonable control, including natural disasters, pandemics, governmental actions, network failures, or cyberattacks.
10. Indemnification
You agree to indemnify, defend, and hold harmless the Company and its directors, officers, employees, agents, partners, and affiliates from and against any claims, liabilities, damages, losses, costs, or expenses (including reasonable legal fees) arising out of or in connection with:
• Your violation of these Terms;
• Your unauthorised or improper use of the Platform, Mobilab Analyzer, or any associated data;
• Your violation of any applicable law, regulation, or third-party rights;
• Any misrepresentation made by you in connection with your use of the Platform.
11. Modifications to Terms and Platform
The Company reserves the right to modify these Terms at any time. Users will be notified of material changes via the Platform interface at the next login. Continued use of the Platform after notification constitutes acceptance of the revised Terms. You are responsible for reviewing these Terms periodically.
The Company may also modify, update, or discontinue any feature, component, or service of the Platform at any time. Such modifications will be communicated through the Platform or via registered email.
12. Governing Law and Dispute Resolution
12.1 Governing Law
​
​These Terms shall be governed by and construed in accordance with the laws of the Republic of
India, including but not limited to the Information Technology Act, 2000; the Digital Personal
Data Protection Act, 2023; the Consumer Protection Act, 2019; and the Indian Contract Act,
1872. For Clients or users located within the European Economic Area (EEA), the United
Kingdom, or other jurisdictions where the General Data Protection Regulation (GDPR) (EU)
2016/679 or equivalent legislation applies, the relevant data protection provisions of those
jurisdictions shall additionally apply to the processing of personal data. In the event of a conflict
between Indian law and GDPR obligations, Mobilab shall apply the stricter standard in relation to
personal data protection.
​
12.2 Dispute Resolution
In the event of any dispute arising out of or relating to these Terms, the parties shall first attempt
resolution through good-faith negotiation. If unresolved within thirty (30) days, the dispute shall
be referred to arbitration in accordance with the Arbitration and Conciliation Act, 1996. The seat
of arbitration shall be [City], India, and proceedings shall be conducted in English.
12.3 Jurisdiction
Without prejudice to the arbitration clause above, the courts at [City], India shall have exclusive
jurisdiction over any matter not subject to arbitration under these Terms.
13. General Provisions
• Severability: If any provision of these Terms is found invalid or unenforceable, it shall be
modified to the minimum extent necessary, and the remaining provisions shall continue
in full force and effect.
• Entire Agreement: These Terms, together with the Privacy Policy and any separate
service agreement between the Company and a Client, constitute the entire agreement
between the parties with respect to the Platform.
• No Waiver: Failure by the Company to enforce any provision of these Terms shall not
constitute a waiver of that right.
• Assignment: You may not assign your rights or obligations under these Terms without
prior written consent from the Company. The Company may assign its rights freely.
• Electronic Communications: By using the Platform, you consent to receive
communications from the Company in electronic form. Such communications satisfy any
requirement for written communication under applicable law.
• Language: These Terms are drafted in English. In case of any inconsistency with a
translated version, the English text shall prevail.
14. Contact Information
For any questions, concerns, or complaints regarding these Terms, please reach out to Mobilab
through the official contact channels listed on our website at www.mobilab.in. Legal and
compliance enquiries may be directed to legal@mobilab.in.